Novo Nordisk has launched Wegovy, a weight loss injection, in India, challenging Eli Lilly's Mounjaro. Available by June 2025 ...

Wegovy, a weight-loss injection containing semaglutide, has arrived in India, offering a new approach to combatting obesity ...

Combination therapy with a long-acting amylin analogue and a glucagon-like peptide-1 (GLP-1) receptor agonist results in ...

Danish drugmaker Novo Nordisk has launched its popular weight-loss drug Wegovy in India, months after its rival Mounjaro’s ...

In a Phase II trial, Amgen’s investigational therapy MariTide (maridebart cafraglutide) delivered significant, sustained ...

Novo Nordisk launches Wegovy® in India, a weight management therapy reducing cardiovascular risks for people with obesity.

A new study from Case Western Reserve School of Medicine suggests that GLP-1 weight loss drugs like Ozempic and Wegovy could ...

Novo Nordisk had been providing Hims & Hers with the FDA-approved Wegovy, an injectable semaglutide used for weight loss ...

Is Ozempic for weight loss helpful? A host of Hollywood celebrities have admitted to using Ozempic, which has become widely ...

Novo Nordisk has launched Wegovy in India, a weight-loss drug challenging Eli Lilly's Mounjaro. Available by June 2025, ...

The 0.25mg, 0.5mg and 1mg dosage of Wegovy will cost ₹17,345 for a month. A higher dose form of 1.75mg will cost ₹24,280 a month, while 2.4mg dose will be for ₹26,050. The drug follows a four-week ...

Wegovy is being made available in five dosing strengths with an easy-to-use pen device, which does away the use of syringes ...